John K. Fallon
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
- Pharmacology 25
- Pharmacogenetics and Drug Metabolism 24
- Oncology 16
- Drug Transport and Resistance Mechanisms 16
- Co-authors
- Philip C. Smith (41 shared papers)David Cowan (8 shared papers)Andrew T. Kicman (8 shared papers)Andrew J. Hutt (4 shared papers)Mary L. Forsling (5 shared papers)Theunis C. Goosen (3 shared papers)Hendrik Neubert (2 shared papers)Yan Ma (6 shared papers)
- Journals
- Drug Metabolism and Disposition (12 papers)Frontiers in Pharmacology (6 papers)The AAPS Journal (4 papers)Journal of Pharmaceutical Sciences (3 papers)Journal of Biological Engineering (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
John K. Fallon
66 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 79
- Pharmacology 555
- Biomaterials 272
- Toxicology 86
- Oncology 220
- Pharmaceutical Science 60
Countries citing papers authored by John K. Fallon
This map shows the geographic impact of John K. Fallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Fallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Fallon more than expected).
Fields of papers citing papers by John K. Fallon
This network shows the impact of papers produced by John K. Fallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Fallon. The network helps show where John K. Fallon may publish in the future.
Co-authors
The 25 scholars most cited alongside John K. Fallon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 242 | |
| 2 | 2011 | 157 | |
| 3 | 1998 | 123 | |
| 4 | 2013 | 114 | |
| 5 | 1999 | 98 | |
| 6 | 2014 | 93 | |
| 7 | 2013 | 84 | |
| 8 | 2015 | 84 | |
| 9 | 2002 | 64 | |
| 10 | 2013 | 62 | |
| 11 | 2010 | 56 | |
| 12 | 2016 | 54 | |
| 13 | 2012 | 53 | |
| 14 | 2015 | 44 | |
| 15 | 2016 | 44 | |
| 16 | 2019 | 44 | |
| 17 | 2008 | 42 | |
| 18 | 2002 | 41 | |
| 19 | 2001 | 37 | |
| 20 | 2017 | 37 |
About John K. Fallon
John K. Fallon is a scholar working on Pharmacology, Oncology, Biomaterials, Pulmonary and Respiratory Medicine and Toxicology, having authored 71 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Drug Transport and Resistance Mechanisms (16 papers), Nanoparticle-Based Drug Delivery (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Extracellular vesicles in disease (2 papers), HIV/AIDS drug development and treatment (2 papers), Psychedelics and Drug Studies (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Pharmacology (555 citations), Biomaterials (272 citations), Toxicology (86 citations), Oncology (220 citations) and Pharmaceutical Science (60 citations). John K. Fallon has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Philip C. Smith, David Cowan, Andrew T. Kicman, Andrew J. Hutt, Mary L. Forsling, Theunis C. Goosen, Hendrik Neubert, Yan Ma, John Aaron Henry and Zhonggui He. Their work appears in journals such as Drug Metabolism and Disposition, Frontiers in Pharmacology, The AAPS Journal, Journal of Pharmaceutical Sciences and Journal of Biological Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.